A "skinny" label is useful for a generic company to supply a drug for a disease, which is separate from another disease that a brand company may hold a valid patent for.
In the case of Amarin vs. Hickma and Healthnet, generic V , which legally is only able to be prescribed for high Trigs, is also being used for CVD, for which Amarin holds a valid patent.
This means that the defendants are not selling Generic V under a "skinny" label, but under a "partial" label...Under a "partial" label, Generic V is BOTH being used legally for high trigs and illegally for the patented CVD indication.
In the course of selling Generic V under this "partial"label, The defendants are infringing on the CVD label and should be subject to paying damages to Amarin.
Market Data 
Markets 
AI
